You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Mucopolysaccharidoses

Showing 1 - 25 of 164
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Iris Cameras in Mucopolysaccharidoses

Not yet recruiting
  • Mucopolysaccharidoses
  • Imaging
  • Manchester, United Kingdom
    Manchester University NHS Foundation Trust
Aug 30, 2022

Cardiovascular Structure and Function in Mucopolysaccharidoses

Recruiting
  • Mucopolysaccharidoses
  • +3 more
  • Carotid ultrasonography
  • +2 more
  • Orange, California
    Children's Hospital of Orange County
Jul 18, 2022

Set for Head, Neck and Respiratory Disease in

Completed
  • Mucopolysaccharidosis Type II
    • Manchester, Lancashire, United Kingdom
      Manchester University NHS Foundation Trust
    Aug 31, 2023

    MPS VII, Mucopolysaccharidosis VII, Sly Syndrome Trial (Mepsevii)

    Available
    • MPS VII
    • +2 more
    • (no location specified)
    Nov 22, 2022

    Mucopolysaccharidosis III-A Trial in Hamburg (JR-441)

    Recruiting
    • Mucopolysaccharidosis III-A
    • Hamburg, Germany
      Universitätsklinikum Hamburg-Eppendorf
    Oct 18, 2023

    Long Term Follow-Up for RGX-111

    Enrolling by invitation
    • Mucopolysaccharidosis I
    • No Intervention
    • Orange, California
    • +2 more
    Oct 25, 2023

    Participants With Sanfilippo Syndrome Type IIIC

    Not yet recruiting
    • Sanfilippo Syndrome Type C
      • Bron, France
        Hospices Civils De Lyon
      Apr 20, 2023

      Hunter Syndrome Trial in Lexington

      Recruiting
      • Hunter Syndrome
        • Lexington, Massachusetts
          Shire
        Nov 7, 2022

        Mucopolysaccharidosis I Trial in Wuhan (Laronidase)

        Recruiting
        • Mucopolysaccharidosis I
        • Wuhan, China
          Investigational Site Number :1560001
        Jan 15, 2023

        Mucopolysaccharidosis II Trial in Porto Alegre, São Paulo (JR-141)

        Completed
        • Mucopolysaccharidosis II
        • Porto Alegre, Brazil
        • +1 more
        Nov 10, 2022

        Mucopolysaccharidosis IH/S, Mucopolysaccharidosis IS Trial in Minneapolis (Autologous Plasmablasts (B cells))

        Not yet recruiting
        • Mucopolysaccharidosis IH/S
        • Mucopolysaccharidosis IS
        • Autologous Plasmablasts (B cells)
        • Minneapolis, Minnesota
          University of Minnesota
        Jan 20, 2023

        MPS II Immunophenotyping

        Recruiting
        • MPS II
        • +2 more
          • Durham, North Carolina
            Duke University
          Jun 3, 2022

          Adrenoleukodystrophy, Batten Disease, Mucopolysaccharidosis II Trial in Durham (DUOC-01)

          Recruiting
          • Adrenoleukodystrophy
          • +11 more
          • DUOC-01
          • Durham, North Carolina
            Duke University Medical Center
          Oct 24, 2022

          Before and After Hematopoietic Cell Transplantation in

          Enrolling by invitation
          • Hematopoietic Cell Transplantation
          • Mucopolysaccharidosis Type I
          • Laronidase therapy and a stem cell transplant
          • Minneapolis, Minnesota
            University of Minnesota Masonic Cancer Center
          Nov 22, 2022

          Mucopolysaccharidosis II Trial in Cincinnati (DNL310)

          Enrolling by invitation
          • Mucopolysaccharidosis II
          • Cincinnati, Ohio
            Cincinnati Children's Hospital Medical Center
          Oct 10, 2023

          Mucopolysaccharidosis II Trial in Oakland (JR-141)

          Not yet recruiting
          • Mucopolysaccharidosis II
          • Oakland, California
            UCSF Benioff Children's Hospital Oakland
          Oct 21, 2022

          MPS I Trial in Oakland (SB-318)

          Terminated
          Has Results
          • MPS I
          • SB-318
          • Oakland, California
            UCSF Benioff Children's Hospital Oakland
          Jan 6, 2023

          Mucopolysaccharidosis Type II Observational

          Withdrawn
          • Mucopolysaccharidosis II
          • Observational
          • Oakland, California
          • +2 more
          Oct 6, 2022

          Mucopolysaccharidosis Type IH (MPS IH, Hurler Syndrome), Mucopolysaccharidosis Type IH, MPS IH, Hurler Syndrome Trial

          Withdrawn
          • Mucopolysaccharidosis Type IH (MPS IH, Hurler Syndrome)
          • +2 more
          • Autologous Plasmablasts
          • (no location specified)
          Oct 5, 2022

          MPS I, MPS1-S, MPS1-HS Trial in Porto Alegre, London, Salford (SIG-005 (hIDUA Producing Spheres))

          Withdrawn
          • MPS I
          • +2 more
          • SIG-005 (hIDUA Producing Spheres)
          • Porto Alegre, Brazil
          • +2 more
          Dec 16, 2022

          Mucopolysaccharidosis I, Mucopolysaccharidosis II, Mucopolysaccharidosis IV A Trial in San Francisco (There is no intervention)

          Recruiting
          • Mucopolysaccharidosis I
          • +7 more
          • There is no intervention
          • San Francisco, California
            University of California San Francisco
          Nov 9, 2022

          Mucopolysaccharidosis Type I (MPS I), Hurler Syndrome, Hurler-Scheie Syndrome Trial in Orange, Philadelphia, Porto Alegre

          Active, not recruiting
          • Mucopolysaccharidosis Type I (MPS I)
          • +2 more
          • RGX-111
          • Orange, California
          • +3 more
          Jan 9, 2023

          Mucopolysaccharidosis (MPS), Hunter Syndrome Trial (ELAPRASE, Rituximab, Methotrexate)

          Not yet recruiting
          • Mucopolysaccharidosis (MPS)
          • Hunter Syndrome
          • (no location specified)
          Aug 8, 2022

          Mucopolysaccharidosis II Trial (Autologous CD34+ HSCs transduced ex vivo with CD11B LV encoding human IDS tagged with ApoEII)

          Not yet recruiting
          • Mucopolysaccharidosis II
          • Autologous CD34+ HSCs transduced ex vivo with CD11B LV encoding human IDS tagged with ApoEII
          • (no location specified)
          Dec 16, 2022

          Study of Patients With MPS IIIA Treated With ABO-102

          Enrolling by invitation
          • Mucopolysaccharidosis III-A
          • ABO-102
          • Columbus, Ohio
          • +2 more
          Nov 8, 2022